在用dupilumab治疗的严重喘患者中,并发症作为个性化的目标
Carlota Gonzalez-Lluch1, Maria Basagaña2, Laura Pardo1
1Department of Ear, Nose and Throat, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Barcelona, Spain.
Journal of personalized medicine
|October 28, 2025
概括
杜皮卢马布显著改善了喘控制,并减少了现实世界队列中的恶化,包括患有严重不受控制的喘和CRSwNP,支气管切开症或肥胖等并发症的患者. 这种生物疗法为难以管理的喘病例提供了有价值的治疗选择.
科学领域:
- 肺病学和呼吸系统医学
- 临床免疫学和过敏学
- 药理学和治疗学 药理学和治疗学
背景情况:
- 严重的失控喘通常涉及2型炎症和并发症.
- 在临床实践中,评估dupilumab等生物制剂的实际有效性至关重要.
- 杜皮卢马布针对2型炎症的关键途径,显示出严重喘的前景.
研究的目的:
- 评估dupilumab在真实生活中的严重喘患者队列中的临床有效性.
- 评估dupilumab对CRSwNP和2型炎症生物标志物的影响.
- 分析dupilumab在患有并发症 (支气管炎症,肥胖症) 或先前生物使用的患者中的疗效.
主要方法:
- 一个单一的中心,前性,实践研究.
- 包括患有或没有CRSwNP,支气管切除,肥胖或生物切换的严重喘患者.
- 评估喘控制测试 (ACT) 分数,恶化频率,SNOT22和VAS分数.
主要成果:
- 在ACT得分 (13.7至20.6) 显著增加和恶化 (3.1至0.7) 总体下降.
- 在子组中观察到的积极结果:CRSwNP,鼻,支气管切除,肥胖和犀牛结膜炎.
- 鼻息肉患者的SNOT22和全球VAS得分有所改善; 支气管切除症患者在治疗后没有恶化.
结论:
- 杜皮卢马布在严重喘中表现出高效,改善了肺功能和生活质量.
- 这种药物对患有2型炎症和伴随性疾病 (如支气管炎症或肥胖) 的患者有益.
- 现实世界的数据支持dupilumab作为一种有价值的治疗选择,即使在其他生物药物失败后.
相关概念视频
01:20Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
01:30Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
01:24Asthma-III: Symptoms and Complications
3.2K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.2K
01:26Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
01:26COPD: Management Using Bronchodilators and Corticosteroids
719
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
719
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K